Compounds and compositions for inhibition of FASN
US-10472342-B2 · Nov 12, 2019 · US
US10995078B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10995078-B2 |
| Application number | US-202015929751-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 20, 2020 |
| Priority date | Mar 13, 2013 |
| Publication date | May 4, 2021 |
| Grant date | May 4, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to compounds and composition for inhibition of FASN, their synthesis, applications, and antidotes. An illustrative compound of the invention is shown below:
Opening claim text (preview).
What is claimed is: 1. A compound selected from the group consisting of: NAME Structure 1-({4-[(4- phenylphenyl)carbonyl]piperazin-1- yl}carbonyl)cyclopropan-1-ol 2-hydroxy-2-methyl-1-{4-[(4- phenylphenyl)carbonyl]piperazin-1- yl}propan-1-one 2-hydroxy-1-{4-[(4- phenylphenyl)carbonyl]piperazin-1- yl}ethan-1-one 1-({4-[(4- phenylphenyl)carbonyl]piperazin-1- yl}carbonyl)cyclopentan-1-ol 3,3,3-trifluoro-2-hydroxy-2-methyl-1- {4[(4- phenylphenyl)carbonyl]piperazin-1- yl}propan-1-one 1-[(4-{[4-(3- methylphenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(4- methylphenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(2-fluoro-3- methoxyphenyl)phenyl]carbonyl} piperazin-1-yl)carbonyl]cyclopropan-1- ol 1-[(4-{[4-(2-fluoro-4- methylphenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(2-fluoro-4- methoxyphenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(2-chloro-4- fluorophenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(3-chloro-4- fluorophenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(4-chloro-2- fluorophenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(2,4- dichlorophenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(5-fluoro-2- methylphenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(3-fluoro-5- methylphenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(2,3- dichlorophenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(2,5- dichlorophenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(4-chloro-3- fluorophenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(2,5- difluorophenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan-1-ol 1-[(4-{[4-(3,4- difluorophenyl)phenyl]carbonyl}piperazin- 1-yl)carbonyl]cyclopropan
Non-condensed pyrazines · CPC title
from aromatic carboxylic acids · CPC title
linked by a carbon chain containing aromatic rings · CPC title
linked by a carbon chain containing aromatic rings · CPC title
linked by a carbon chain containing aromatic rings · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.